Table 1.
Demographics and Clinical Characteristics of SCZ and HCs
| Characteristics | SCZ(n = 120) Mean (SD) |
HCs(n = 65) Mean (SD) |
Statistics (χ2/t) |
P-value |
|---|---|---|---|---|
| Sex (M/F) | 70/50 | 38/27 | 2.85 × 10−4 | .987 |
| Age (years) | 40.76 (13.10) | 37.48 (12.31) | 1.66 | .098 |
| Education (year) | 12.23(3.09) | 13.42(2.54) | −2.66 | .009 |
| BMI (kg/m2) | 24.08(4.39) | 24.03(3.11) | 0.86 | .932 |
| Illness duration (month) | 19.99(13.04) | NA | NA | NA |
| PANSS | ||||
| Total Score | 69.49(19.45) | NA | NA | NA |
| P-Subscale | 18.62(7.35) | NA | NA | NA |
| N-Subscale | 17.58(7.34) | NA | NA | NA |
| G-Subscale | 33.30(9.73) | NA | NA | NA |
| CPZ | 346.91(214.12) | NA | NA | NA |
Note: SCZ, patients with schizophrenia; HCs, healthy controls; BMI, body mass index; PANSS, Positive and Negative Symptom Scale; CPZ, antipsychotic dosage by chlorpromazine equivalents; NA, not application.
The bold font represents P < .05.